Patents by Inventor Alan Lader

Alan Lader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating ischemia and ischemia-reperfusion injury
    Patent number: 8772249
    Abstract: The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula I: and methods of using such compounds to activate cytoprotective kinases. The values and preferred values of the variables in Structural Formula I are defined herein.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: July 8, 2014
    Assignee: Ischemix, LLC
    Inventors: Alexander Baguisi, Reinier Beeuwkes, Ralph Casale, Steven A. Kates, Alan Lader
  • COMPOSITIONS AND METHODS FOR TREATING ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY
    Publication number: 20110160294
    Abstract: The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula I: and methods of using such compounds to activate cytoprotective kinases. The values and preferred values of the variables in Structural Formula I are defined herein.
    Type: Application
    Filed: March 4, 2011
    Publication date: June 30, 2011
    Applicant: Ischemix LLC
    Inventors: Alexander Baguisi, Reinier Beeuwkes, Ralph Casale, Steven A. Kates, Alan Lader
  • Compositions and methods for treating ischemia and ischemia-reperfusion injury
    Patent number: 7928067
    Abstract: The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula II: and methods of using such compounds to activate cytoprotective kinases.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: April 19, 2011
    Assignee: Ischemix LLC
    Inventors: Alexander Baguisi, Reinier Beeuwkes, Ralph Casale, Steven A. Kates, Alan Lader
  • COMPOSITIONS AND METHODS FOR TREATING ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY
    Publication number: 20100292313
    Abstract: The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula II: and methods of using such compounds to activate cytoprotective kinases.
    Type: Application
    Filed: May 14, 2009
    Publication date: November 18, 2010
    Inventors: Alexander Baguisi, Reinier Beeuwkes, Ralph Casale, Steven A. Kates, Alan Lader